Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent in pure of Calidi Biotherapeutics, Inc. from 2022 to 2024

Taxonomy & unit
us-gaap: pure
Description
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
Summary
Calidi Biotherapeutics, Inc. quarterly/annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent history and change rate from 2022 to 2024.
  • Calidi Biotherapeutics, Inc. Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for the quarter ending 31 Mar 2023 was 0.21 pure.
  • Calidi Biotherapeutics, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2024 was 0.21 pure, unchanged from 2023.
  • Calidi Biotherapeutics, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2023 was 0.21 pure, unchanged from 2022.
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Quarterly (pure)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Annual (pure)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, YoY Annual Change (%)

Calidi Biotherapeutics, Inc. Quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent (pure)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 0.21 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023

Calidi Biotherapeutics, Inc. Annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent (pure)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 0.21 0 0% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025
2023 0.21 0 0% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025
2022 0.21 01 Jan 2022 31 Dec 2022 10-K 15 Mar 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.